{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:22Z","timestamp":1707525142198},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,17]]},"DOI":"10.7759\/cureus.39119","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T08:56:16Z","timestamp":1684313776000},"source":"Crossref","is-referenced-by-count":0,"title":["Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study"],"prefix":"10.7759","author":[{"given":"Elvina","family":"Almuradova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suayib","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rukiye","family":"Ar\u0131kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Ayhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hacer","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokcen Tugba","family":"Cevik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Petekkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Karabulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708. Epub 2022 Jan 12","article-title":"","volume":"72","author":"Siegel RL","year":"20222022","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al.. Cancer statistics. 20222022, 72:7. 10.3322\/caac.21708. Epub 2022 Jan 12","journal-title":"Cancer statistics"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492. Epub 2018 Sep 12.","article-title":"Global cancer statistics","volume":"68","author":"Bray F","year":"2018361852018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al.. Global cancer statistics. 2018361852018, 68:394-424. 10.3322\/caac.21492. Epub 2018 Sep 12."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2482-10-27","article-title":"Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis","volume":"10","author":"Hayashi M","year":"2010","unstructured":"Hayashi M, Inoue Y, Komeda K, et al.. Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis. BMC Surg. 2010, 10:27. 10.1186\/1471-2482-10-27","journal-title":"BMC Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9215-5","article-title":"Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis","volume":"14","author":"Tsai MS","year":"2007","unstructured":"Tsai MS, Su YH, Ho MC, Liang JT, Chen TP, Lai HS, Lee PH. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol. 2007, 14:786-94. 10.1245\/s10434-006-9215-5","journal-title":"Ann Surg Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones R","year":"2017","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A, Arnold D. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017, 28:iv22-40. 10.1093\/annonc\/mdx224","journal-title":"Ann Oncol"},{"key":"ref6","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Available at. https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx (Accessed on April 12. (2021). https:\/\/www.nccn.org\/guidelines\/category_1."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00262","article-title":"Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment","volume":"3","author":"Thies S","year":"2013","unstructured":"Thies S, Langer R. Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment. Front Oncol. 2013, 3:262. 10.3389\/fonc.2013.00262","journal-title":"Front Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800821034","article-title":"Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Fran\u00e7aise de Canc\u00e9rologie Digestive","volume":"82","author":"Rougier P","year":"1995","unstructured":"Rougier P, Milan C, Lazorthes F, Fourtanier G, Partensky C, Baumel H, Faivre J. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Fran\u00e7aise de Canc\u00e9rologie Digestive. Br J Surg. 1995, 82:1397-400. 10.1002\/bjs.1800821034","journal-title":"Br J Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31819a0486","article-title":"Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil\/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases","volume":"249","author":"Masi G","year":"2009","unstructured":"Masi G, Loupakis F, Pollina L, et al.. Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil\/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg. 2009, 249:420-5. 10.1097\/SLA.0b013e31819a0486","journal-title":"Ann Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.9273","article-title":"Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?","volume":"27","author":"Adam R","year":"2009","unstructured":"Adam R, Wicherts DA, de Haas RJ, et al.. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?. J Clin Oncol. 2009, 27:1829-35. 10.1200\/JCO.2008.19.9273","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5505\/aot.2016.80299","article-title":"Pulmonary Metastasectomy For 29 Patients With Colorectal Carcinoma: A Single Center Experience","volume":"11","author":"Cengizhan MS","year":"2016","unstructured":"Cengizhan MS, \u00d6ztop I, Salman T, et al.. Pulmonary Metastasectomy For 29 Patients With Colorectal Carcinoma: A Single Center Experience. AOT. 2016, 11:197-205. 10.5505\/aot.2016.80299","journal-title":"AOT"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008347829017","article-title":"Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery","volume":"10","author":"Giacchetti S","year":"1999","unstructured":"Giacchetti S, Itzhaki M, Gruia G, et al.. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 1999, 10:663-9. 10.1023\/a:1008347829017","journal-title":"Ann Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000138076.72547.b1","article-title":"Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET)","volume":"240","author":"Fernandez FG","year":"2004","unstructured":"Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg. 2004, 240:438-47; discussion 447-50. 10.1097\/01.sla.0000138076.72547.b1","journal-title":"Ann Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000141198.92114.f6","article-title":"Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival","volume":"240","author":"Adam R","year":"2004","unstructured":"Adam R, Delvart V, Pascal G, et al.. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004, 240:644-57; discussion 657-8. 10.1097\/01.sla.0000141198.92114.f6","journal-title":"Ann Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2020.1213","article-title":"Pulmonary Metastasectomy in Colorectal Cancer: A Population-Based Retrospective Cohort Study Using the Korean National Health Insurance Database","volume":"53","author":"Yu WS","year":"2021","unstructured":"Yu WS, Bae MK, Choi JK, Hong YK, Park IK. Pulmonary Metastasectomy in Colorectal Cancer: A Population-Based Retrospective Cohort Study Using the Korean National Health Insurance Database. Cancer Res Treat. 2021, 53:1104-12. 10.4143\/crt.2020.1213","journal-title":"Cancer Res Treat"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.211557","article-title":"Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study","volume":"59","author":"Mitry E","year":"2010","unstructured":"Mitry E, Guiu B, Cosconea S, Jooste V, Faivre J, Bouvier AM. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut. 2010, 59:1383-8. 10.1136\/gut.2010.211557","journal-title":"Gut"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2019.09.06","article-title":"Is metastasectomy a worthy option?-the role of surgery in metastatic colon cancer to liver and lungs","volume":"10","author":"Lemini R","year":"2019","unstructured":"Lemini R, Attwood K, Almerey T, et al.. Is metastasectomy a worthy option?-the role of surgery in metastatic colon cancer to liver and lungs. J Gastrointest Oncol. 2019, 10:1032-48. 10.21037\/jgo.2019.09.06","journal-title":"J Gastrointest Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-12-197","article-title":"Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy","volume":"12","author":"Chiang JM","year":"2014","unstructured":"Chiang JM, Hsieh PS, Chen JS, Tang R, You JF, Yeh CY. Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy. World J Surg Oncol. 2014, 12:197. 10.1186\/1477-7819-12-197","journal-title":"World J Surg Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-018-0987-0","article-title":"Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle\/lower rectal cancer","volume":"13","author":"Huang MY","year":"2018","unstructured":"Huang MY, Lee HH, Tsai HL, et al.. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle\/lower rectal cancer. Radiat Oncol. 2018, 13:53. 10.1186\/s13014-018-0987-0","journal-title":"Radiat Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2482-10-17","article-title":"Predicting survival after pulmonary metastasectomy for colorectal cancer: previous liver metastases matter","volume":"10","author":"Landes U","year":"2010","unstructured":"Landes U, Robert J, Perneger T, Mentha G, Ott V, Morel P, Gervaz P. Predicting survival after pulmonary metastasectomy for colorectal cancer: previous liver metastases matter. BMC Surg. 2010, 10:17. 10.1186\/1471-2482-10-17","journal-title":"BMC Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-016-0940-3","article-title":"Prognostic factors after pulmonary metastasectomy of colorectal cancers: influence of liver metastasis","volume":"14","author":"Kim S","year":"2016","unstructured":"Kim S, Kim HK, Cho JH, et al.. Prognostic factors after pulmonary metastasectomy of colorectal cancers: influence of liver metastasis. World J Surg Oncol. 2016, 14:201. 10.1186\/s12957-016-0940-3","journal-title":"World J Surg Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(03)00387-9","article-title":"Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma","volume":"197","author":"Mineo TC","year":"2003","unstructured":"Mineo TC, Ambrogi V, Tonini G, et al.. Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg. 2003, 197:386-91. 10.1016\/S1072-7515(03)00387-9","journal-title":"J Am Coll Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2005.025","article-title":"Oncogenic Ras in tumour progression and metastasis","volume":"386","author":"Giehl K","year":"2005","unstructured":"Giehl K. Oncogenic Ras in tumour progression and metastasis. Biol Chem. 2005, 386:193-205. 10.1515\/BC.2005.025","journal-title":"Biol Chem"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.2887","article-title":"Impact of Subsequent Therapies on Outcome of the FIRE-3\/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal Cancer","volume":"33","author":"Modest DP","year":"2015","unstructured":"Modest DP, Stintzing S, von Weikersthal LF, et al.. Impact of Subsequent Therapies on Outcome of the FIRE-3\/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal Cancer. J Clin Oncol. 2015, 33:3718-26. 10.1200\/JCO.2015.61.2887","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/310542","article-title":"Prognostic value of mandard and dworak tumor regression grading in rectal cancer: study of a single tertiary center","volume":"2014","author":"Santos MD","year":"2014","unstructured":"Santos MD, Silva C, Rocha A, Matos E, Nogueira C, Lopes C. Prognostic value of mandard and dworak tumor regression grading in rectal cancer: study of a single tertiary center. ISRN Surg. 2014, 2014:310542. 10.1155\/2014\/310542","journal-title":"ISRN Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14418","article-title":"Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?","volume":"8","author":"Choi JP","year":"2017","unstructured":"Choi JP, Kim SJ, Park IJ, et al.. Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?. Oncotarget. 2017, 8:10375-84. 10.18632\/oncotarget.14418","journal-title":"Oncotarget"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02638-1","article-title":"The effect of BMI on long-term outcome in patients with rectal cancer and establishment of a nomogram prediction model","volume":"23","author":"Zhang Y","year":"2023","unstructured":"Zhang Y, Yang X, Zhuang Z, Wei M, Meng W, Deng X, Wang Z. The effect of BMI on long-term outcome in patients with rectal cancer and establishment of a nomogram prediction model. BMC Gastroenterol. 2023, 23:5. 10.1186\/s12876-023-02638-1","journal-title":"BMC Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s10151-016-1498-3","article-title":"Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis","volume":"20","author":"Doleman B","year":"2016","unstructured":"Doleman B, Mills KT, Lim S, Zelhart MD, Gagliardi G. Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis. Tech Coloproctol. 2016, 20:517-35. 10.1007\/s10151-016-1498-3","journal-title":"Tech Coloproctol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2010.04.006","article-title":"ACR Appropriateness Criteria: rectal cancer-metastatic disease at presentation","volume":"34","author":"Herman J","year":"2010","unstructured":"Herman J, Messersmith W, Suh WW, et al.. ACR Appropriateness Criteria: rectal cancer-metastatic disease at presentation. Curr Probl Cancer. 2010, 34:201-10. 10.1016\/j.currproblcancer.2010.04.006","journal-title":"Curr Probl Cancer"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27567. Epub 2012 Apr 19","article-title":"Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer","volume":"118","author":"Butte JM","year":"2012","unstructured":"Butte JM, Gonen M, Ding P, et al.. Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer. Cancer. 2012, 118:5414. 10.1002\/cncr.27567. Epub 2012 Apr 19","journal-title":"Cancer"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-5-75","article-title":"The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study","volume":"5","author":"Kim JW","year":"2010","unstructured":"Kim JW, Kim YB, Kim NK, et al.. The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study. Radiat Oncol. 2010, 5:75. 10.1186\/1748-717X-5-75","journal-title":"Radiat Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/149126-survival-of-patients-with-metastatic-rectum-cancer-who-underwent-metastasectomy-following-conversion-chemotherapy-sans-pelvic-radiotherapy-a-turkish-oncology-group-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:14Z","timestamp":1707508874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/149126-survival-of-patients-with-metastatic-rectum-cancer-who-underwent-metastasectomy-following-conversion-chemotherapy-sans-pelvic-radiotherapy-a-turkish-oncology-group-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.39119","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,17]]}}}